Association of the ATM gene polymorphisms with papillary thyroid cancer

Endocrine. 2014 Apr;45(3):454-61. doi: 10.1007/s12020-013-0020-1. Epub 2013 Aug 8.

Abstract

Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, yet few genetic markers of PTC risk useful for screening exist. Our study aimed to evaluate the association between single nucleotide polymorphisms (SNPs) of the ataxia telangiectasia mutated (ATM) gene and PTC risk. 358 patients with PTC and 360 healthy controls were included in the case-control study. Four ATM SNPs (rs664677, rs373759, rs4988099, and rs189037) were genotyped by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). The analysis of genetic data was performed using the SNPStats program. The allele frequencies and genotype distributions of the four ATM SNPs were not different between PTC patients and controls. We did not observe any tendency of increasing the frequency of the risk allele from controls, patients without metastasis to patients with metastasis (P(trend) > 0.05). Interestingly, the AG genotype of rs373759 was associated with PTC risk under an overdominant model of inheritance (adjusted OR = 1.38; 95 % CI, 1.03-1.87; P = 0.03). No haplotype was observed to be significantly associated with PTC risk. Our results suggest that heterozygosity for the ATM rs373759 polymorphism may be a potential risk factor for PTC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Ataxia Telangiectasia Mutated Proteins / genetics*
  • Biomarkers, Tumor*
  • Carcinoma / ethnology
  • Carcinoma / genetics*
  • Carcinoma, Papillary
  • Case-Control Studies
  • China / ethnology
  • Female
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease
  • Genotyping Techniques
  • Humans
  • Male
  • Middle Aged
  • Models, Genetic
  • Polymorphism, Single Nucleotide / genetics
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / ethnology
  • Thyroid Neoplasms / genetics*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Ataxia Telangiectasia Mutated Proteins